Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Parvovirus Antigens Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Antigen NS1
1.2.3 Antigen VP1
1.2.4 Antigen VP2
1.2.5 Others
1.3 Market by Application
1.3.1 Global Recombinant Parvovirus Antigens Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Diagnostic Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Parvovirus Antigens Market Perspective (2018-2033)
2.2 Recombinant Parvovirus Antigens Growth Trends by Region
2.2.1 Global Recombinant Parvovirus Antigens Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Recombinant Parvovirus Antigens Historic Market Size by Region (2018-2023)
2.2.3 Recombinant Parvovirus Antigens Forecasted Market Size by Region (2024-2033)
2.3 Recombinant Parvovirus Antigens Market Dynamics
2.3.1 Recombinant Parvovirus Antigens Industry Trends
2.3.2 Recombinant Parvovirus Antigens Market Drivers
2.3.3 Recombinant Parvovirus Antigens Market Challenges
2.3.4 Recombinant Parvovirus Antigens Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Parvovirus Antigens Players by Revenue
3.1.1 Global Top Recombinant Parvovirus Antigens Players by Revenue (2018-2023)
3.1.2 Global Recombinant Parvovirus Antigens Revenue Market Share by Players (2018-2023)
3.2 Global Recombinant Parvovirus Antigens Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant Parvovirus Antigens Revenue
3.4 Global Recombinant Parvovirus Antigens Market Concentration Ratio
3.4.1 Global Recombinant Parvovirus Antigens Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Parvovirus Antigens Revenue in 2022
3.5 Recombinant Parvovirus Antigens Key Players Head office and Area Served
3.6 Key Players Recombinant Parvovirus Antigens Product Solution and Service
3.7 Date of Enter into Recombinant Parvovirus Antigens Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Parvovirus Antigens Breakdown Data by Type
4.1 Global Recombinant Parvovirus Antigens Historic Market Size by Type (2018-2023)
4.2 Global Recombinant Parvovirus Antigens Forecasted Market Size by Type (2024-2033)
5 Recombinant Parvovirus Antigens Breakdown Data by Application
5.1 Global Recombinant Parvovirus Antigens Historic Market Size by Application (2018-2023)
5.2 Global Recombinant Parvovirus Antigens Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Recombinant Parvovirus Antigens Market Size (2018-2033)
6.2 North America Recombinant Parvovirus Antigens Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Recombinant Parvovirus Antigens Market Size by Country (2018-2023)
6.4 North America Recombinant Parvovirus Antigens Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Parvovirus Antigens Market Size (2018-2033)
7.2 Europe Recombinant Parvovirus Antigens Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Recombinant Parvovirus Antigens Market Size by Country (2018-2023)
7.4 Europe Recombinant Parvovirus Antigens Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Parvovirus Antigens Market Size (2018-2033)
8.2 Asia-Pacific Recombinant Parvovirus Antigens Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Recombinant Parvovirus Antigens Market Size by Region (2018-2023)
8.4 Asia-Pacific Recombinant Parvovirus Antigens Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Parvovirus Antigens Market Size (2018-2033)
9.2 Latin America Recombinant Parvovirus Antigens Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Recombinant Parvovirus Antigens Market Size by Country (2018-2023)
9.4 Latin America Recombinant Parvovirus Antigens Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Parvovirus Antigens Market Size (2018-2033)
10.2 Middle East & Africa Recombinant Parvovirus Antigens Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Recombinant Parvovirus Antigens Market Size by Country (2018-2023)
10.4 Middle East & Africa Recombinant Parvovirus Antigens Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ELlTechGroup
11.1.1 ELlTechGroup Company Detail
11.1.2 ELlTechGroup Business Overview
11.1.3 ELlTechGroup Recombinant Parvovirus Antigens Introduction
11.1.4 ELlTechGroup Revenue in Recombinant Parvovirus Antigens Business (2018-2023)
11.1.5 ELlTechGroup Recent Development
11.2 Diesse Diagnostica Senese
11.2.1 Diesse Diagnostica Senese Company Detail
11.2.2 Diesse Diagnostica Senese Business Overview
11.2.3 Diesse Diagnostica Senese Recombinant Parvovirus Antigens Introduction
11.2.4 Diesse Diagnostica Senese Revenue in Recombinant Parvovirus Antigens Business (2018-2023)
11.2.5 Diesse Diagnostica Senese Recent Development
11.3 R-Biopharm AG
11.3.1 R-Biopharm AG Company Detail
11.3.2 R-Biopharm AG Business Overview
11.3.3 R-Biopharm AG Recombinant Parvovirus Antigens Introduction
11.3.4 R-Biopharm AG Revenue in Recombinant Parvovirus Antigens Business (2018-2023)
11.3.5 R-Biopharm AG Recent Development
11.4 Zoetis
11.4.1 Zoetis Company Detail
11.4.2 Zoetis Business Overview
11.4.3 Zoetis Recombinant Parvovirus Antigens Introduction
11.4.4 Zoetis Revenue in Recombinant Parvovirus Antigens Business (2018-2023)
11.4.5 Zoetis Recent Development
11.5 altona Diagnostics GmbH
11.5.1 altona Diagnostics GmbH Company Detail
11.5.2 altona Diagnostics GmbH Business Overview
11.5.3 altona Diagnostics GmbH Recombinant Parvovirus Antigens Introduction
11.5.4 altona Diagnostics GmbH Revenue in Recombinant Parvovirus Antigens Business (2018-2023)
11.5.5 altona Diagnostics GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Recombinant Parvovirus Antigens Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Antigen NS1
Table 3. Key Players of Antigen VP1
Table 4. Key Players of Antigen VP2
Table 5. Key Players of Others
Table 6. Global Recombinant Parvovirus Antigens Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Recombinant Parvovirus Antigens Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Recombinant Parvovirus Antigens Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Recombinant Parvovirus Antigens Market Share by Region (2018-2023)
Table 10. Global Recombinant Parvovirus Antigens Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Recombinant Parvovirus Antigens Market Share by Region (2024-2033)
Table 12. Recombinant Parvovirus Antigens Market Trends
Table 13. Recombinant Parvovirus Antigens Market Drivers
Table 14. Recombinant Parvovirus Antigens Market Challenges
Table 15. Recombinant Parvovirus Antigens Market Restraints
Table 16. Global Recombinant Parvovirus Antigens Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Recombinant Parvovirus Antigens Market Share by Players (2018-2023)
Table 18. Global Top Recombinant Parvovirus Antigens Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Parvovirus Antigens as of 2022)
Table 19. Ranking of Global Top Recombinant Parvovirus Antigens Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Recombinant Parvovirus Antigens Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Recombinant Parvovirus Antigens Product Solution and Service
Table 23. Date of Enter into Recombinant Parvovirus Antigens Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Recombinant Parvovirus Antigens Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Recombinant Parvovirus Antigens Revenue Market Share by Type (2018-2023)
Table 27. Global Recombinant Parvovirus Antigens Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Recombinant Parvovirus Antigens Revenue Market Share by Type (2024-2033)
Table 29. Global Recombinant Parvovirus Antigens Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Recombinant Parvovirus Antigens Revenue Market Share by Application (2018-2023)
Table 31. Global Recombinant Parvovirus Antigens Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Recombinant Parvovirus Antigens Revenue Market Share by Application (2024-2033)
Table 33. North America Recombinant Parvovirus Antigens Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Recombinant Parvovirus Antigens Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Recombinant Parvovirus Antigens Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Recombinant Parvovirus Antigens Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Recombinant Parvovirus Antigens Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Recombinant Parvovirus Antigens Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Recombinant Parvovirus Antigens Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Recombinant Parvovirus Antigens Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Recombinant Parvovirus Antigens Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Recombinant Parvovirus Antigens Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Recombinant Parvovirus Antigens Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Recombinant Parvovirus Antigens Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Recombinant Parvovirus Antigens Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Recombinant Parvovirus Antigens Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Recombinant Parvovirus Antigens Market Size by Country (2024-2033) & (US$ Million)
Table 48. ELlTechGroup Company Detail
Table 49. ELlTechGroup Business Overview
Table 50. ELlTechGroup Recombinant Parvovirus Antigens Product
Table 51. ELlTechGroup Revenue in Recombinant Parvovirus Antigens Business (2018-2023) & (US$ Million)
Table 52. ELlTechGroup Recent Development
Table 53. Diesse Diagnostica Senese Company Detail
Table 54. Diesse Diagnostica Senese Business Overview
Table 55. Diesse Diagnostica Senese Recombinant Parvovirus Antigens Product
Table 56. Diesse Diagnostica Senese Revenue in Recombinant Parvovirus Antigens Business (2018-2023) & (US$ Million)
Table 57. Diesse Diagnostica Senese Recent Development
Table 58. R-Biopharm AG Company Detail
Table 59. R-Biopharm AG Business Overview
Table 60. R-Biopharm AG Recombinant Parvovirus Antigens Product
Table 61. R-Biopharm AG Revenue in Recombinant Parvovirus Antigens Business (2018-2023) & (US$ Million)
Table 62. R-Biopharm AG Recent Development
Table 63. Zoetis Company Detail
Table 64. Zoetis Business Overview
Table 65. Zoetis Recombinant Parvovirus Antigens Product
Table 66. Zoetis Revenue in Recombinant Parvovirus Antigens Business (2018-2023) & (US$ Million)
Table 67. Zoetis Recent Development
Table 68. altona Diagnostics GmbH Company Detail
Table 69. altona Diagnostics GmbH Business Overview
Table 70. altona Diagnostics GmbH Recombinant Parvovirus Antigens Product
Table 71. altona Diagnostics GmbH Revenue in Recombinant Parvovirus Antigens Business (2018-2023) & (US$ Million)
Table 72. altona Diagnostics GmbH Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant Parvovirus Antigens Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Recombinant Parvovirus Antigens Market Share by Type: 2022 VS 2033
Figure 3. Antigen NS1 Features
Figure 4. Antigen VP1 Features
Figure 5. Antigen VP2 Features
Figure 6. Others Features
Figure 7. Global Recombinant Parvovirus Antigens Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Recombinant Parvovirus Antigens Market Share by Application: 2022 VS 2033
Figure 9. Hospital Case Studies
Figure 10. Diagnostic Laboratory Case Studies
Figure 11. Others Case Studies
Figure 12. Recombinant Parvovirus Antigens Report Years Considered
Figure 13. Global Recombinant Parvovirus Antigens Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Recombinant Parvovirus Antigens Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Recombinant Parvovirus Antigens Market Share by Region: 2022 VS 2033
Figure 16. Global Recombinant Parvovirus Antigens Market Share by Players in 2022
Figure 17. Global Top Recombinant Parvovirus Antigens Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Parvovirus Antigens as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Recombinant Parvovirus Antigens Revenue in 2022
Figure 19. North America Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Recombinant Parvovirus Antigens Market Share by Country (2018-2033)
Figure 21. United States Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Recombinant Parvovirus Antigens Market Share by Country (2018-2033)
Figure 25. Germany Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Recombinant Parvovirus Antigens Market Share by Region (2018-2033)
Figure 33. China Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Recombinant Parvovirus Antigens Market Share by Country (2018-2033)
Figure 41. Mexico Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Recombinant Parvovirus Antigens Market Share by Country (2018-2033)
Figure 45. Turkey Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Recombinant Parvovirus Antigens Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. ELlTechGroup Revenue Growth Rate in Recombinant Parvovirus Antigens Business (2018-2023)
Figure 48. Diesse Diagnostica Senese Revenue Growth Rate in Recombinant Parvovirus Antigens Business (2018-2023)
Figure 49. R-Biopharm AG Revenue Growth Rate in Recombinant Parvovirus Antigens Business (2018-2023)
Figure 50. Zoetis Revenue Growth Rate in Recombinant Parvovirus Antigens Business (2018-2023)
Figure 51. altona Diagnostics GmbH Revenue Growth Rate in Recombinant Parvovirus Antigens Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed